60degreespharma.com (SXTP): שווי מצרפי של הפעילות העסקית

The development of anti-infective drugs is constrained by strict FDA oversight and the complexity of field trials in remote areas. In this segment, 60 Degrees Pharmaceuticals (SXTP) maintains its position through unique patents for tropical disease therapies, which minimizes pressure from industry behemoths. This chart confirms that the market price has fixed the enterprise value at 11.21, while production capacities are operating at maximum intensity according to approved plans.

For 60 Degrees Pharmaceuticals (SXTP), whose stability relies on US government contracts and patent protection for tropical infection drugs, the change in EV reflects the actual market value of the business. The current value of 11.21 is calculated as the sum of market capitalization and net debt, allowing an investor to assess the total acquisition cost of the asset, accounting for leverage and liquidity.